DECLARE TIMI 58 (Afgerond)
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)
- Middel
- dapagliflozin
- Populatie
- diabetes mellitus
- Fase
- III
- Jaar aanvang
- 2013
- Meer informatie
- ClinicalTrials.gov